Detalhe da pesquisa
1.
Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials.
Blood
; 142(3): 235-243, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140031
2.
Facets of physical function assessed by patient-reported outcome measures in oncology research.
Qual Life Res
; 33(7): 1819-1828, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642217
3.
What facets of physical function are most important to adults diagnosed with cancer?
Qual Life Res
; 33(7): 1829-1839, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642219
4.
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Lancet Oncol
; 24(2): e86-e95, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725153
5.
Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
Qual Life Res
; 32(8): 2281-2292, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935467
6.
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials.
Lancet Oncol
; 23(5): e229-e234, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489354
7.
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancer.
Cancer
; 128(4): 808-818, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634139
8.
US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast Cancer.
Value Health
; 25(4): 566-570, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365300
9.
Timing is everything: The importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events.
Clin Trials
; 19(3): 267-273, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575012
10.
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines.
JAMA
; 327(19): 1910-1919, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579638
11.
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Lancet Oncol
; 22(9): 1230-1239, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310904
12.
Does Knowledge of Treatment Assignment Affect Patient Report of Symptoms, Function, and Health Status? An Evaluation Using Multiple Myeloma Trials.
Value Health
; 24(6): 822-829, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119080
13.
Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types.
Value Health
; 24(9): 1302-1307, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452710
14.
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Qual Life Res
; 29(7): 1903-1911, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32100182
15.
Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratification.
Pharmacoepidemiol Drug Saf
; 28(10): 1386-1394, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410963
16.
Reply to "Another look at floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning subscale and possible solutions".
Cancer
; 128(12): 2386-2387, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389509
17.
FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy.
Oncologist
; 22(11): 1347-1353, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28904172
18.
The FDA's patient-focused drug development initiative.
Clin Adv Hematol Oncol
; 19(2): 70-72, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596186
19.
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.
Cancer
; 121(7): 1064-70, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25469920
20.
Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.
Oncologist
; 25(10): 819-821, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463153